CIM
IRWD icon

CIM Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

CIM Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,708
Closed -$164K – 316
2021
Q1 		$164K Sell
14,708
-877
-6% -$9.27K 0.05% 293
2020
Q4 		$178K Hold
15,585
– – 0.06% 278
2020
Q3 		$140K Buy
15,585
+225
+1% +$2.24K 0.05% 250
2020
Q2 		$159K Buy
+15,360
New +$157K 0.06% 235

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

CIM Investment Management's IRWD Position: Q2 2021 in Review

CIM Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2021, closing a stake of 14,708 shares — an estimated $164K sold.

CIM Investment Management first reported a position in IRWD in Q2 2020 and held it in 4 quarters. The position peaked at $178K in Q4 2020. 208 funds tracked by Wall St. Rank hold IRWD as of Q2 2021.

  • CIM Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • CIM Investment Management sold 14,708 Ironwood Pharmaceuticals shares in Q2 2021, an estimated $164K.
  • CIM Investment Management first reported a position in Ironwood Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • CIM Investment Management's Ironwood Pharmaceuticals position peaked at $178K in Q4 2020.
  • 208 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2021.

Based on CIM Investment Management's 13F filing for Q2 2021, filed 13 Aug 2021.